Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 697 of 1,261
  1. US 9322021

    Methods for modulating kallikrein (KLKB1) expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  2. US 9320714

    Tablet

    Takeda Pharmaceutical Company Limited · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  3. US 9320592

    Coated medical devices and methods of making and using same

    Covidien LP · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  4. US 9322005

    DNA-binding proteins and uses thereof

    Sangamo Biosciences, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  5. US 9322018

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  6. US 9321820

    Compositions and methods for treating bladder cancer

    The Regents of the University of Colorado · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  7. US 9322010

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  8. US 9321999

    Compositions for increasing polypeptide stability and activity, and related methods

    Solis BioDyne OÜ · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  9. US 9321813

    Methods and compositions for cytomegalovirus IL-10 protein

    The Regents of the University of California · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  10. US 9321799

    Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

    Ionis Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  11. US 9321763

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  12. US 9321772

    Substituted pyrazolo[3,4-D]pyrimidines and uses thereof

    The Regents of the University of California · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  13. US 9321757

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  14. US 9321743

    Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase

    The Regents of the University of California · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  15. US 9321811

    Further novel anti-parasitic compounds

    The Regents of the University of California · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  16. US 9321725

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  17. US 9320827

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  18. US 9321128

    High power laser system

    United States of America as represented by the Secretary of the Air Force · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  19. US 9320808

    Acid salt forms of polymer-drug conjugates and alkoxylation methods

    Nektar Therapeutics · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  20. US 9320774

    Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer

    China Medical University · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  21. US 9320789

    Combinations of gene deletions for live attenuated shigella vaccine strains

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  22. US 9320786

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  23. US 9320793

    Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42

    Acumen Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  24. US 9320765

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.